Save time and get answers to complex questions with AI chat
Drugpatentwatch market analysis industry today?Dabrafenib patent expiration?Is guselkumab off patent in u s?What excipients are combined with ruxolitinib in apotex's medication?Are there income restrictions for lipitor's patient program?
See the DrugPatentWatch profile for Prevymis
Yes. Prevymis (letermovir) is available as an oral medication. - Indication: CMV prophylaxis in CMV-seropositive adults (and select pediatric HSCT patients) after engraftment. - Oral dose (adult): typically 480 mg once daily, taken with or without food, starting within 24 hours after engraftment and continuing through week 14 post-transplant. - If taking cyclosporine: dose is usually reduced to 240 mg once daily. - IV form: there is an intravenous formulation if oral dosing isn’t possible. - Important: not for treatment of active CMV infection; has drug interactions (e.g., rifampin decreases exposure; cyclosporine increases exposure). If you share more about age, transplant status, and other meds, I can tailor the dosing info.
Other Questions About Prevymis :